Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., . . . Yeh, H. (2011). Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. Journal of clinical oncology, 29(9), 1125. https://doi.org/10.1200/JCO.2010.31.3304
Citace podle Chicago (17th ed.)Henry, David H., et al. "Randomized, Double-blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients with Advanced Cancer (excluding Breast and Prostate Cancer) or Multiple Myeloma." Journal of Clinical Oncology 29, no. 9 (2011): 1125. https://doi.org/10.1200/JCO.2010.31.3304.
Citace podle MLA (9th ed.)Henry, David H., et al. "Randomized, Double-blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients with Advanced Cancer (excluding Breast and Prostate Cancer) or Multiple Myeloma." Journal of Clinical Oncology, vol. 29, no. 9, 2011, p. 1125, https://doi.org/10.1200/JCO.2010.31.3304.